213 related articles for article (PubMed ID: 25978047)
1. Killer Cell Immunoglobulin-like Receptors and Their HLA Ligands are Related with the Immunopathology of Chagas Disease.
Ayo CM; Reis PG; Dalalio MM; Visentainer JE; Oliveira Cde F; de Araújo SM; de Oliveira Marques DS; Sell AM
PLoS Negl Trop Dis; 2015 May; 9(5):e0003753. PubMed ID: 25978047
[TBL] [Abstract][Full Text] [Related]
2. Large spectrum of HLA-C recognition by killer Ig-like receptor (KIR)2DL2 and KIR2DL3 and restricted C1 SPECIFICITY of KIR2DS2: dominant impact of KIR2DL2/KIR2DS2 on KIR2D NK cell repertoire formation.
David G; Djaoud Z; Willem C; Legrand N; Rettman P; Gagne K; Cesbron A; Retière C
J Immunol; 2013 Nov; 191(9):4778-88. PubMed ID: 24078689
[TBL] [Abstract][Full Text] [Related]
3. Killer cell immunoglobulin-like receptor (KIR) genes in systemic sclerosis.
Salim PH; Jobim M; Bredemeier M; Chies JA; Schlottfeldt J; Brenol JC; Jobim LF; Xavier RM
Clin Exp Immunol; 2010 Jun; 160(3):325-30. PubMed ID: 20082621
[TBL] [Abstract][Full Text] [Related]
4. Increased frequencies of the killer immunoglobulin-like receptor genes KIR2DL2 and KIR2DS2 are associated with neuroblastoma.
Keating SE; Ní Chorcora C; Dring MM; Stallings RL; O'Meara A; Gardiner CM
Tissue Antigens; 2015 Sep; 86(3):172-7. PubMed ID: 26202659
[TBL] [Abstract][Full Text] [Related]
5.
Ayo CM; Bestetti RB; de Campos Junior E; Ronchi LS; Borim AA; Brandão CC; de Matttos LC
Front Immunol; 2021; 12():714766. PubMed ID: 34489964
[TBL] [Abstract][Full Text] [Related]
6. Associations between genes for killer immunoglobulin-like receptors and their ligands in patients with epithelial ovarian cancer.
Giebel S; Boratyn-Nowicka A; Karabon L; Jedynak A; Pamula-Pilat J; Tecza K; Kula D; Kowal M; Frydecka I; Grzybowska E
Hum Immunol; 2014 Jun; 75(6):508-13. PubMed ID: 24755350
[TBL] [Abstract][Full Text] [Related]
7. KIR2DL2 and KIR2DS2 as genetic markers to the methotrexate response in rheumatoid arthritis patients.
Velarde-de la Cruz EE; Sánchez-Hernández PE; Muñoz-Valle JF; Palafox-Sánchez CA; Ramírez-de Los Santos S; Graciano-Machuca O; García-Iglesias T; Montoya-Buelna M; Ramírez-Dueñas MG
Immunopharmacol Immunotoxicol; 2016 Aug; 38(4):303-9. PubMed ID: 27251940
[TBL] [Abstract][Full Text] [Related]
8. Natural killer cell receptor variants and chronic hepatitis B virus infection in the Vietnamese population.
Auer ED; Tong HV; Amorim LM; Malheiros D; Hoan NX; Issler HC; Petzl-Erler ML; Beltrame MH; Boldt ABW; Toan NL; Song LH; Velavan TP; Augusto DG
Int J Infect Dis; 2020 Jul; 96():541-547. PubMed ID: 32422377
[TBL] [Abstract][Full Text] [Related]
9. The investigation of killer cell immunoglobulin-like receptor genotyping in patients with systemic lupus erytematosus and systemic sclerosis.
Tozkır JD; Tozkır H; Gürkan H; Dönmez S; Eker D; Pamuk GE; Pamuk ÖN
Clin Rheumatol; 2016 Apr; 35(4):919-25. PubMed ID: 26960450
[TBL] [Abstract][Full Text] [Related]
10. Killer immunoglobulin receptor genes and their HLA-C ligand are associated with Type 1 diabetes in an Eastern Indian population.
Sanjeevi S; Sun C; Kanungo A; Sanjeevi CB
Diabet Med; 2016 Jan; 33(1):91-6. PubMed ID: 26031759
[TBL] [Abstract][Full Text] [Related]
11. Polymorphic HLA-C Receptors Balance the Functional Characteristics of KIR Haplotypes.
Hilton HG; Guethlein LA; Goyos A; Nemat-Gorgani N; Bushnell DA; Norman PJ; Parham P
J Immunol; 2015 Oct; 195(7):3160-70. PubMed ID: 26311903
[TBL] [Abstract][Full Text] [Related]
12. Clinical and histopathological changes in different KIR gene profiles in chronic HCV Romanian patients.
Ursu LD; Calenic B; Diculescu M; Dima A; Stoian IT; Constantinescu I
Int J Immunogenet; 2021 Feb; 48(1):16-24. PubMed ID: 32961633
[TBL] [Abstract][Full Text] [Related]
13. KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR GENES AND THEIR HLA-C LIGANDS IN HASHIMOTO THYROIDITIS IN A CHINESE POPULATION.
Li JT; Guo C; Li ML; Wei YQ; Hou YF; Jiao YL; Zhao YR; Sun H; Xu J; Cao MF; Feng L; Yu GN; Gao L; Liu YQ; Zhang BC; Zhao JJ; Zhang HQ
Endocr Pract; 2016 Aug; 22(8):935-40. PubMed ID: 27042744
[TBL] [Abstract][Full Text] [Related]
14. Killer immunoglobulin-like receptors (KIR2DL2 and/or KIR2DS2) in presence of their ligand (HLA-C1 group) protect against chronic myeloid leukaemia.
Middleton D; Diler AS; Meenagh A; Sleator C; Gourraud PA
Tissue Antigens; 2009 Jun; 73(6):553-60. PubMed ID: 19493232
[TBL] [Abstract][Full Text] [Related]
15. Genetic epistasis between killer immunoglobulin-like receptors and human leukocyte antigens in Kawasaki disease susceptibility.
Bossi G; Mannarino S; Pietrogrande MC; Salice P; Dellepiane RM; Cremaschi AL; Corana G; Tozzo A; Capittini C; De Silvestri A; Tinelli C; Pasi A; Martinetti M
Genes Immun; 2015 Oct; 16(7):481-7. PubMed ID: 26335810
[TBL] [Abstract][Full Text] [Related]
16. Killer-cell immunoglobulin-like receptor gene polymorphisms and susceptibility to psoriatic arthritis.
Chandran V; Bull SB; Pellett FJ; Ayearst R; Pollock RA; Gladman DD
Rheumatology (Oxford); 2014 Feb; 53(2):233-9. PubMed ID: 24185760
[TBL] [Abstract][Full Text] [Related]
17. Lack of killer immunoglobulin-like receptor 2DS2 (KIR2DS2) and KIR2DL2 is associated with poor responses to therapy of recurrent hepatitis C virus in liver transplant recipients.
Askar M; Avery R; Corey R; Lopez R; Thomas D; Pidwell D; Eghtesad B; Miller C; Fung J; Zein NN
Liver Transpl; 2009 Nov; 15(11):1557-63. PubMed ID: 19877200
[TBL] [Abstract][Full Text] [Related]
18. Conjunctival scarring in trachoma is associated with the HLA-C ligand of KIR and is exacerbated by heterozygosity at KIR2DL2/KIR2DL3.
Roberts CH; Molina S; Makalo P; Joof H; Harding-Esch EM; Burr SE; Mabey DC; Bailey RL; Burton MJ; Holland MJ
PLoS Negl Trop Dis; 2014 Mar; 8(3):e2744. PubMed ID: 24651768
[TBL] [Abstract][Full Text] [Related]
19. Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians.
Shastry A; Sedimbi SK; Rajalingam R; Nikitina-Zake L; Rumba I; Wigzell H; Sanjeevi CB
Int J Immunogenet; 2008 Dec; 35(6):439-46. PubMed ID: 19046302
[TBL] [Abstract][Full Text] [Related]
20. The effect of missing KIR ligands, activating KIR genotype and haplotype on the outcome of T-cell-replete hematopoietic stem cell transplantation from HLA-identical siblings in Thai patients.
Khanuntong S; Kuptawintu P; Upaisilpsathaporn K; Poolchareon A; Bunworasate U; Hirankarn N
HLA; 2016 Jun; 87(6):422-31. PubMed ID: 27273744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
